GlassScriptPhysician profile
Kathleen A Jackson
NPI 1548236029
$4,182.55
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,927 · 2020: $1,422 · 2021: $833.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $798.55 | 2019-2021 | |
| Amgen INC. | $620.40 | 2019-2021 | |
| Pfizer INC. | $497.21 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $218.90 | 2019-2021 | |
| Abbvie INC. | $203.84 | 2019-2021 | |
| Glaxosmithkline, LLC. | $199.31 | 2019-2021 | |
| Therapeuticsmd, INC. | $198.44 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $193.65 | 2019-2021 | |
| Amarin Pharma, INC. | $155.46 | 2020-2021 | |
| Allergan, INC. | $125.95 | 2019 | |
| Lilly USA, LLC | $118.96 | 2019-2021 | |
| Novo Nordisk INC | $109.63 | 2019-2020 | |
| Daiichi Sankyo INC. | $91.72 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $85.43 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $79.04 | 2019-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $77.43 | 2019-2021 | |
| Astellas Pharma US INC | $61.36 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $50.44 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $48.63 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.58 | 2019 | |
| Merck Sharp & Dohme LLC | $38.70 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $31.86 | 2019-2021 | |
| Eisai INC. | $28.86 | 2020-2021 | |
| Nestle Healthcare Nutrition INC. | $24.37 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $23.42 | 2021 | |
| Celgene Corporation | $23.00 | 2019 | |
| Boston Scientific Corporation | $19.41 | 2021 | |
| Horizon Therapeutics Plc | $18.00 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.